SONOMA PHARMACEUTICALS, INC. Increase (Decrease) in Accounts Payable and Accrued Liabilities
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$779.00 thousand for the 9-month period ending 2020-12-31, per its 10-Q filed 2021-02-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2021-02-16
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2020-12-31 was $81.00K, a 125.00% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2020-09-30 was $87.00K.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2020-06-30 was -$947.00K.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2020-03-31 was $416.00K.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2020 was $330.00K, a 186.96% increase from fiscal 2019.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2019 was $115.00K, a 139.58% increase from fiscal 2018.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2018 was $48.00K.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in accounts payable and accrued liabilities for fiscal 2017 was -$298.00K, a 132.43% decline from fiscal 2016.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | $81.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-16 | $168.00K derived: sum of 2 quarters · filed 2021-02-16 | -$779.00K 10-Q · filed 2021-02-16 | -$363.00K derived: sum of 4 quarters · filed 2021-02-16 | ||||
| 2020-09-30 | $87.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2020-11-20 | -$860.00K 10-Q · filed 2020-11-20 | -$444.00K derived: sum of 3 quarters · filed 2020-11-20 | -$408.00K derived: sum of 4 quarters · filed 2021-02-16 | ||||
| 2020-06-30 | -$947.00K 10-Q/A · filed 2020-11-17 | -$1.12M 10-Q · filed 2020-08-14 | -$531.00K derived: sum of 2 quarters · filed 2020-11-17 | -$495.00K derived: sum of 3 quarters · filed 2021-02-16 | -$527.00K derived: sum of 4 quarters · filed 2021-02-16 | |||
| 2020-03-31 | $416.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-10 | $452.00K derived: sum of 2 quarters · filed 2021-02-16 | $420.00K derived: sum of 3 quarters · filed 2021-02-16 | $330.00K 10-K · filed 2020-07-10 | ||||
| 2019-12-31 | $36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-16 | $4.00K derived: sum of 2 quarters · filed 2021-02-16 | -$86.00K 10-Q · filed 2021-02-16 | -$121.00K derived: sum of 4 quarters · filed 2021-02-16 | ||||
| 2019-09-30 | -$32.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2020-11-20 | -$122.00K 10-Q · filed 2020-11-20 | -$157.00K derived: sum of 3 quarters · filed 2020-11-20 | $140.00K derived: sum of 4 quarters · filed 2020-11-20 | ||||
| 2019-06-30 | -$90.00K 10-Q/A · filed 2020-11-17 | -$125.00K derived: sum of 2 quarters · filed 2020-11-17 | $172.00K derived: sum of 3 quarters · filed 2020-11-17 | -$212.00K derived: sum of 4 quarters · filed 2020-11-17 | ||||
| 2019-03-31 | -$35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-10 | $262.00K derived: sum of 2 quarters · filed 2020-07-10 | -$122.00K derived: sum of 3 quarters · filed 2020-07-10 | $115.00K 10-K · filed 2020-07-10 | ||||
| 2018-12-31 | $297.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-14 | -$87.00K derived: sum of 2 quarters · filed 2020-02-14 | $150.00K 10-Q · filed 2020-02-14 | $24.00K derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2018-09-30 | -$384.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-14 | -$147.00K 10-Q · filed 2019-11-14 | -$273.00K derived: sum of 3 quarters · filed 2019-11-14 | -$133.00K derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | $237.00K 10-Q · filed 2019-08-13 | $111.00K derived: sum of 2 quarters · filed 2019-08-13 | $251.00K derived: sum of 3 quarters · filed 2019-08-13 | $79.00K derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2018-03-31 | -$126.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-01 | $14.00K derived: sum of 2 quarters · filed 2019-07-01 | -$158.00K derived: sum of 3 quarters · filed 2019-07-01 | $48.00K 10-K · filed 2019-07-01 | ||||
| 2017-12-31 | $140.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-14 | -$32.00K derived: sum of 2 quarters · filed 2019-02-14 | $174.00K 10-Q · filed 2019-02-14 | -$210.00K derived: sum of 4 quarters · filed 2019-02-14 | ||||
| 2017-09-30 | -$172.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-08 | $34.00K 10-Q · filed 2018-11-08 | -$350.00K derived: sum of 3 quarters · filed 2018-11-08 | $118.00K derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | $206.00K 10-Q · filed 2018-08-08 | -$178.00K derived: sum of 2 quarters · filed 2018-08-08 | $290.00K derived: sum of 3 quarters · filed 2018-08-08 | $34.00K derived: sum of 4 quarters · filed 2018-08-08 | ||||
| 2017-03-31 | -$384.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-26 | $84.00K derived: sum of 2 quarters · filed 2018-06-26 | -$172.00K derived: sum of 3 quarters · filed 2018-06-26 | -$298.00K 10-K · filed 2018-06-26 | ||||
| 2016-12-31 | $468.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-14 | $212.00K derived: sum of 2 quarters · filed 2018-02-14 | $86.00K 10-Q · filed 2018-02-14 | $728.00K derived: sum of 4 quarters · filed 2018-02-14 | ||||
| 2016-09-30 | -$256.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-14 | -$382.00K 10-Q · filed 2017-11-14 | $260.00K derived: sum of 3 quarters · filed 2017-11-14 | $171.00K derived: sum of 4 quarters · filed 2017-11-14 | ||||
| 2016-06-30 | -$126.00K 10-Q · filed 2017-08-08 | $516.00K derived: sum of 2 quarters · filed 2017-08-08 | $427.00K derived: sum of 3 quarters · filed 2017-08-08 | $528.00K derived: sum of 4 quarters · filed 2017-08-08 | ||||
| 2016-03-31 | $642.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-28 | $553.00K derived: sum of 2 quarters · filed 2017-06-28 | $654.00K derived: sum of 3 quarters · filed 2017-06-28 | $919.00K 10-K · filed 2017-06-28 | ||||
| 2015-12-31 | -$89.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-17 | $12.00K derived: sum of 2 quarters · filed 2017-02-17 | $277.00K 10-Q · filed 2017-02-17 | $150.00K derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-09-30 | $101.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-15 | $366.00K 10-Q · filed 2016-11-15 | $239.00K derived: sum of 3 quarters · filed 2016-11-15 | $523.00K derived: sum of 4 quarters · filed 2016-11-15 | ||||
| 2015-06-30 | $265.00K 10-Q · filed 2016-08-09 | $138.00K derived: sum of 2 quarters · filed 2016-08-09 | $422.00K derived: sum of 3 quarters · filed 2016-08-09 | $305.00K derived: sum of 4 quarters · filed 2016-08-09 | ||||
| 2015-03-31 | -$127.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-21 | $157.00K derived: sum of 2 quarters · filed 2016-06-21 | $40.00K derived: sum of 3 quarters · filed 2016-06-21 | -$1.00K 10-K · filed 2016-06-21 | ||||
| 2014-12-31 | $284.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-16 | $167.00K derived: sum of 2 quarters · filed 2016-02-16 | $126.00K 10-Q · filed 2016-02-16 | $449.00K derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-09-30 | -$117.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-10 | -$158.00K 10-Q · filed 2015-11-10 | $165.00K derived: sum of 3 quarters · filed 2015-11-10 | $37.00K derived: sum of 4 quarters · filed 2015-11-10 | ||||
| 2014-06-30 | -$41.00K 10-Q · filed 2015-08-07 | $282.00K derived: sum of 2 quarters · filed 2015-08-07 | $154.00K derived: sum of 3 quarters · filed 2015-08-07 | $258.00K derived: sum of 4 quarters · filed 2015-08-07 | ||||
| 2014-03-31 | $323.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-16 | $195.00K derived: sum of 2 quarters · filed 2015-06-16 | $299.00K derived: sum of 3 quarters · filed 2015-06-16 | $271.00K 10-K · filed 2015-06-16 | ||||
| 2013-12-31 | -$128.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-12 | -$24.00K derived: sum of 2 quarters · filed 2015-02-12 | -$52.00K 10-Q · filed 2015-02-12 | -$471.00K derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-09-30 | $104.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-13 | $76.00K 10-Q · filed 2014-11-13 | -$343.00K derived: sum of 3 quarters · filed 2014-11-13 | $6.00K derived: sum of 4 quarters · filed 2014-11-13 | ||||
| 2013-06-30 | -$28.00K 10-Q · filed 2014-08-12 | -$447.00K derived: sum of 2 quarters · filed 2014-08-12 | -$98.00K derived: sum of 3 quarters · filed 2014-08-12 | -$190.00K derived: sum of 4 quarters · filed 2014-08-12 | ||||
| 2013-03-31 | -$419.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-30 | -$70.00K derived: sum of 2 quarters · filed 2014-06-30 | -$162.00K derived: sum of 3 quarters · filed 2014-06-30 | -$141.00K 10-K · filed 2014-06-30 | ||||
| 2012-12-31 | $349.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-14 | $257.00K derived: sum of 2 quarters · filed 2014-02-14 | $278.00K 10-Q · filed 2014-02-14 | $4.05M 10-Q · filed 2013-02-13 | $310.00K derived: sum of 4 quarters · filed 2014-02-14 | |||
| 2012-09-30 | -$92.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-19 | -$71.00K 10-Q · filed 2013-11-19 | $4.41M 10-Q · filed 2012-11-08 | -$39.00K derived: sum of 3 quarters · filed 2013-11-19 | -$132.00K derived: sum of 4 quarters · filed 2013-11-19 | |||
| 2012-06-30 | $21.00K 10-Q · filed 2013-08-14 | $24.00K 10-Q/A · filed 2012-08-31 | $53.00K derived: sum of 2 quarters · filed 2013-08-14 | -$40.00K derived: sum of 3 quarters · filed 2013-08-14 | -$359.00K derived: sum of 4 quarters · filed 2013-08-14 | |||
| 2012-03-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-25 | -$61.00K derived: sum of 2 quarters · filed 2013-06-25 | -$380.00K derived: sum of 3 quarters · filed 2013-06-25 | $150.00K 10-K · filed 2013-06-25 | -$19.00K 10-K · filed 2012-06-21 | |||
| 2011-12-31 | -$93.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-13 | -$412.00K derived: sum of 2 quarters · filed 2013-02-13 | $118.00K 10-Q · filed 2013-02-13 | $1.40M derived: sum of 4 quarters · filed 2013-02-13 | ||||
| 2011-09-30 | -$319.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2012-11-08 | $211.00K 10-Q · filed 2012-11-08 | $1.49M derived: sum of 3 quarters · filed 2012-11-08 | |||||
| 2011-06-30 | $530.00K 10-Q/A · filed 2012-08-31 | $1.81M derived: sum of 2 quarters · filed 2012-08-31 | ||||||
| 2011-03-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2012-06-21 | $1.23M 10-K · filed 2012-06-21 | ||||||
| 2010-12-31 | -$53.00K 10-Q · filed 2012-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |